TNF inhibitors

DRUG3 trials

Sponsors

Columbia University, Diakonhjemmet Hospital, Mohamed Nasr

Conditions

Inflammatory Bowel Disease (IBD)Rheumatoid ArthritisSpondylarthropathiesTNF-alpha Inhibitors

Phase 4

RHYTHM (Formerly Escape II Myocardium)

CompletedNCT01548768

Columbia UniversityRheumatoid Arthritis

Start: 2011-10-10End: 2019-09-30Updated: 2020-11-27

Assessing Withdrawal of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis

CompletedNCT01881308

Diakonhjemmet HospitalRheumatoid Arthritis

Start: 2013-06-17End: 2022-01-31Updated: 2022-04-26

Unknown Phase

Prevelance of Axial Spondylosis Arthritis in Inflammatory Bowel Disease and Its RESPONSE to Tumour Necrosis Factor (TNF) Inhibitors Treatment in Assiut University Hospital

Not yet recruitingNCT06601595

Mohamed NasrInflammatory Bowel Disease (IBD), Spondylarthropathies, TNF-alpha Inhibitors

Start: 2024-10-31End: 2026-03-31Target: 100Updated: 2024-09-19

Related Papers

Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND): 3-year results from an open-label, randomised controlled, non-inferiority trial.

2024-04-046 citations

Performance of the Rheumatoid Arthritis Impact of Disease (RAID) score in relation to flares in disease activity

RMD Open2024-01-014 citations

Effect of tapered versus stable treatment with tumour necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission: a randomised, open label, non-inferiority trial.

2023-08-229 citations

Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in Remission

JAMA2021-05-0426 citations